Keywords: fda, review, ista, hemorrhage, drug, usa-based, pharmaceuticals

FDA to review ISTA's hemorrhage drug

Article | 03 February 2003

Print This

USA-based ISTA Pharmaceuticals has said the the Food and DrugAdministration will consider the company's New Drug Application for its Vitrase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in